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We plan to begin the verifications requested by PubMed Central in January 2019, while the verifications for Thomson Reuters (Analytics) will start at the end of next year. All these steps that we are willing to take are only made possible by your interest and professionalism and therefore we would like to thank all of you for the support.
Introduction
Wheezing is the most frequent clinical finding in pediatric pulmonary disorders, approximately 30% of children manifest an episode of wheezing during their lives [1, 2] .
Recurrent wheezing, demonstrated by repeating attacks of wheezes is a common complaint in pediatric everyday practice. Having a high chance to happen, the progression into asthma in some cases with recurrent wheezing lay down a possibility of early treatment modalities before developpment of pulmonary remodelling phenomenon and deterioration of pulmonary functions [3] . Accordingly, noticable discussions have erupted regarding the classification and treatment of preschoolers complaining of wheezing episodes and in order to wrap them up, the primary aetiology and pathophysiological mechanisms of these episodes have to be accurately explained [1, 4, 5] .
Epidemiology
Recurrent wheeze and dyspnea in preschool children was studied in more cohort studies on a large-scale age. As a landmark study
